TMEM106A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.003400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.297000E-01
Normal-vs-Stage2
3.240800E-01
Normal-vs-Stage3
1.434850E-01
Normal-vs-Stage4
3.807200E-01
Stage1-vs-Stage2
1.780430E-01
Stage1-vs-Stage3
8.504400E-01
Stage1-vs-Stage4
2.515900E-02
Stage2-vs-Stage3
3.618800E-01
Stage2-vs-Stage4
2.771000E-01
Stage3-vs-Stage4
1.634810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.996000E-01
Normal-vs-AfricanAmerican
2.816800E-01
Normal-vs-Asian
5.093600E-02
Caucasian-vs-AfricanAmerican
7.576400E-01
Caucasian-vs-Asian
6.494600E-01
AfricanAmerican-vs-Asian
9.753000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.011200E-01
Normal-vs-Female
3.010800E-01
Male-vs-Female
9.972000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.356400E-01
Normal-vs-Age(41-60Yrs)
3.402800E-01
Normal-vs-Age(61-80Yrs)
2.836000E-01
Normal-vs-Age(81-100Yrs)
2.939200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.799400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.703000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.114000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.109230E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.166800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.359800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.763200E-01
Normal-vs-Daily Drinker
2.601400E-01
Normal-vs-Weekly Drinker
1.143430E-01
Normal-vs-Occasional Drinker
2.965200E-01
Normal-vs-Social Drinker
3.663800E-01
Non Drinker-vs-Daily Drinker
7.309200E-01
Non Drinker-vs-Weekly Drinker
2.411400E-01
Non Drinker-vs-Occasional Drinker
7.512400E-01
Non Drinker-vs-Social Drinker
2.127200E-01
Daily Drinker-vs-Weekly Drinker
1.766850E-01
Daily Drinker-vs-Occasional Drinker
5.442000E-01
Daily Drinker-vs-Social Drinker
1.431840E-01
Weekly Drinker-vs-Occasional Drinker
4.129800E-01
Weekly Drinker-vs-Social Drinker
9.684600E-01
Occasional Drinker-vs-Social Drinker
3.775400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.884800E-01
Normal-vs-Grade 2
9.375400E-01
Normal-vs-Grade 3
9.923600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.220790E-03
Grade 1-vs-Grade 3
3.216000E-04
Grade 1-vs-Grade 4
7.884800E-01
Grade 2-vs-Grade 3
8.786200E-02
Grade 2-vs-Grade 4
9.375400E-01
Grade 3-vs-Grade 4
9.923600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.828000E-01
Normal-vs-NonDiabetic
2.904200E-01
Diabetic-vs-NonDiabetic
7.902000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.168800E-01
Normal-vs-NoPancreatitis
2.902600E-01
Pancreatitis-vs-NoPancreatitis
5.422200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.655200E-01
Normal-vs-N1
3.207000E-01
N0-vs-N1
8.298000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.740200E-01
Normal-vs-TP53-NonMutant
1.905630E-01
TP53-Mutant-vs-TP53-NonMutant
2.774200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
